The defense ‘exit problem’, big pharma, and perverse incentives
press.airstreet.com
We explore the challenge of defense exits in Europe, looking at the lessons the defense primes could take from another oligopoly, before returning to our favorite set of broken incentives.
The defense ‘exit problem’, big pharma, and perverse incentives
The defense ‘exit problem’, big pharma, and…
The defense ‘exit problem’, big pharma, and perverse incentives
We explore the challenge of defense exits in Europe, looking at the lessons the defense primes could take from another oligopoly, before returning to our favorite set of broken incentives.